The author references the point you are making: he isn't reporting on mescaline, but on the experiences reported by early western users. He too points out that

The author references the point you are making: he isn't reporting on mescaline, but on the experiences reported by early western users. He too points out that they were largely responsive to the visual aspects of the drug, and theorizes why.